Haizhou Lou

668 total citations
21 papers, 379 citations indexed

About

Haizhou Lou is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haizhou Lou has authored 21 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haizhou Lou's work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Haizhou Lou is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Haizhou Lou collaborates with scholars based in China, Nepal and United States. Haizhou Lou's co-authors include Hongming Pan, Pan Qin, Da Li, Yong Fang, Yinghua Xu, Wei Chen, Xiao Liang, Kaifeng Wang, Lü Tian and Zhengbo Song and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Haizhou Lou

19 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haizhou Lou China 10 121 119 107 88 67 21 379
Cailing Gan China 12 198 1.6× 113 0.9× 89 0.8× 134 1.5× 162 2.4× 24 551
Guowen Yin China 11 96 0.8× 136 1.1× 61 0.6× 77 0.9× 66 1.0× 25 348
Naveenkumar Perumal United States 12 256 2.1× 79 0.7× 97 0.9× 66 0.8× 47 0.7× 17 454
Hongbo Du China 9 123 1.0× 84 0.7× 60 0.6× 88 1.0× 40 0.6× 27 342
Yanjun Shen China 10 93 0.8× 148 1.2× 80 0.7× 83 0.9× 56 0.8× 16 362
Yuqing Wang China 8 146 1.2× 94 0.8× 76 0.7× 35 0.4× 35 0.5× 21 402
Teresa Peccerella Germany 14 172 1.4× 86 0.7× 111 1.0× 191 2.2× 41 0.6× 35 556
Masahiko Sunaga Japan 13 233 1.9× 76 0.6× 123 1.1× 79 0.9× 37 0.6× 25 491
Mamoru Morimoto Japan 14 127 1.0× 40 0.3× 143 1.3× 46 0.5× 130 1.9× 40 538

Countries citing papers authored by Haizhou Lou

Since Specialization
Citations

This map shows the geographic impact of Haizhou Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haizhou Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haizhou Lou more than expected).

Fields of papers citing papers by Haizhou Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haizhou Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haizhou Lou. The network helps show where Haizhou Lou may publish in the future.

Co-authorship network of co-authors of Haizhou Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Haizhou Lou. A scholar is included among the top collaborators of Haizhou Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haizhou Lou. Haizhou Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Li, Hongsen, Huanqing Cheng, Huina Wang, et al.. (2022). Comprehensive Molecular Profiling of Colorectal Cancer With Situs Inversus Totalis by Next-Generation Sequencing. Frontiers in Oncology. 12. 813253–813253.
5.
Chen, Jianxin & Haizhou Lou. (2021). Complete Response to Pembrolizumab in Advanced Colon Cancer Harboring Somatic POLE F367S Mutation with Microsatellite Stability Status: A Case Study. OncoTargets and Therapy. Volume 14. 1791–1796. 9 indexed citations
6.
Zheng, Hui, Wenchao Zhu, Hongsen Li, et al.. (2021). Novel Nutrition-Based Nomograms to Assess the Outcomes of Lung Cancer Patients Treated With Anlotinib or Apatinib. Frontiers in Oncology. 11. 628693–628693. 3 indexed citations
7.
Zheng, Hui, Wenchao Zhu, Hongsen Li, et al.. (2021). A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer. Frontiers in Nutrition. 8. 664620–664620. 4 indexed citations
8.
Jiang, Xinrong, Xiaohong Chen, Chen Zhao, et al.. (2021). High-Throughput Salivary Metabolite Profiling on an Ultralow Noise Tip-Enhanced Laser Desorption Ionization Mass Spectrometry Platform for Noninvasive Diagnosis of Early Lung Cancer. Journal of Proteome Research. 20(9). 4346–4356. 20 indexed citations
9.
Xia, Yan, Lihong Shen, Lisha Li, et al.. (2020). Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody. Cancer Immunology Immunotherapy. 70(2). 533–546. 15 indexed citations
10.
Lou, Haizhou, et al.. (2020). NF1 germline mutation in a Chinese family with colon cancer. Journal of International Medical Research. 48(8). 1219695987–1219695987. 1 indexed citations
11.
Ye, Bo, et al.. (2019). MADD Expression in Lung Adenocarcinoma and its Impact on Proliferation and Apoptosis of Lung Adenocarcinoma Cells. Combinatorial Chemistry & High Throughput Screening. 22(3). 207–215. 3 indexed citations
12.
Fang, Yong, Yulong Zheng, Jun Chen, et al.. (2018). Genetic mutation as biomarker for advanced cancer patients receiving apatinib: An analysis based on whole exome sequencing.. Journal of Clinical Oncology. 36(15_suppl). e24219–e24219. 1 indexed citations
13.
Chen, Enguo, Pin Wang, Haizhou Lou, et al.. (2017). A robust gene expression-based prognostic risk score predicts overall survival of lung adenocarcinoma patients. Oncotarget. 9(6). 6862–6871. 5 indexed citations
14.
Lou, Fang, Yu Zheng, Haizhou Lou, et al.. (2016). Thermal Radiofrequency Ablation as an Adjuvant Therapy for Patients With Colorectal Liver Metastasis. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 23(5). 219–228. 4 indexed citations
15.
Lou, Haizhou, Hongming Pan, Pan Qin, et al.. (2014). The novel mTORC1/2 dual inhibitor INK-128 suppresses survival and proliferation of primary and transformed human pancreatic cancer cells. Biochemical and Biophysical Research Communications. 450(2). 973–978. 25 indexed citations
16.
Lou, Haizhou. (2014). Colonic metastasis after resection of primary squamous cell carcinoma of the lung: A case report and literature review. World Journal of Gastroenterology. 20(19). 5930–5930. 9 indexed citations
18.
Qin, Pan, Hongming Pan, Haizhou Lou, Yinghua Xu, & Lü Tian. (2013). Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo. Cancer Cell International. 13(1). 69–69. 73 indexed citations
19.
Fang, Yong, Wei Chen, Xiao Liang, et al.. (2013). Comparison of long‐term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 29(1). 193–200. 124 indexed citations
20.
Lou, Haizhou, et al.. (2007). [Clinical study on treatment of primary liver cancer by Aidi injection combined with cool-tip radiofrequency ablation].. PubMed. 27(5). 393–5. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026